Human Longevity, Inc. (HLI) Hires Key Oncology Leader, Kenneth J. Bloom, M.D., to Head Oncology and Immunotherapy Program
Stephen P. Schoenberger, Ph.D., to head cancer vaccine program and Ezra Cohen, M.D. is staff oncologist (SAN DIEGO...
Human Longevity Inc. Advances Leadership Role in Newborn Genome Sequencing with Strategic Acquisition of Stem Cell Banking from Celgene Cellular Therapeutics
HLI to Offer Newborn Genome Sequencing Product in Combination with Stem Cell Banking (SAN DIEGO, CA)—January 28,...
Human Longevity, Inc. (HLI) to Offer Oncology Products Including Comprehensive Whole Germline, Tumor Genome and Whole Cancer Exome Products
(SAN DIEGO, CA)—January 12, 2016—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, an...
Human Longevity, Inc. (HLI) Acquires Cypher Genomics, Inc.
Cypher CEO, Ashley Van Zeeland, Ph.D. to become head of HLI’s Pediatric Business (SAN DIEGO, CA)—November 30,...
- .@HumanLongevity Hires Key Oncology Leader, Kenneth J. Bloom, M.D., to Head Oncology and Immunotherapy Program https://t.co/Yf3d2B2mJd
[4 days ago]
- RT @NewRepublic: What’s wrong with Craig Venter? https://t.co/Ud3PGg8ZQ2 https://t.co/wfgsWm42lj
[4 days ago]
- RT @ClintonFdn: Is genetic testing affordable? Dr. J Craig Venter of @JCVenterInst provides a cost comparison at #HealthMatters2016. https:…
[1 week ago]
Using the combined power of our core areas of expertise—genomics, informatics, and stem cell therapies, we are tackling one of the greatest medical/scientific and societal challenges—aging and aging related diseases. –Dr. J. Craig Venter
The global market for healthy human longevity is enormous with total healthcare expenditures in those 65 and older running well over $7 trillion. We believe that HLI’s unique science and technology, along with our business leadership, will positively impact the healthcare market with novel diagnostics and therapeutics. –Dr. Robert Hariri
HLI is going to change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model which we believe will lower healthcare costs. Our goal is not necessarily lengthening life, but extending a healthier, high performing, more productive life span. –Dr. J. Craig Venter
Between 1910 and 2010 improvements in medicine and sanitation increased the human lifespan by 50 percent from 50 to 75 years. Today with the emergence of exponential technologies such as those being pioneered and advanced by HLI we have the potential to meaningfully extend the lifespan even further. –Dr. Peter H. Diamandis